Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SLC13A5 Deficiency: a Prospective Natural History Study - Remote Only (International)

NCT04681781 is registered in ClinicalTrials.gov with TESS Research Foundation as lead sponsor.

NCT NCT04681781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04681781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SLC13A5 Deficiency: a Prospective Natural History Study - Remote Only (International)
Lead sponsor
TESS Research Foundation
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2021
Completion date
September 1, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

17p13.1 deletions confined to slc13a5 gene, citrate transporter deficiency, citrate transporter disorder, eiee25, epilepsy, genetic disorder, kohlschutter-tonz syndrome (non-rogdi), movement disorders, rare diseases, slc13a5 deficiency